AGP Executive Report
Last update: 8 hours agoMedication Safety: The FDA is requiring vision-loss warnings on GLP-1 drugs such as Ozempic, Wegovy and Zepbound, citing a possible rare risk of a serious optic-nerve condition. Rural Care: States received a second year of federal rural-health funding, including more than $202 million for West Virginia, $197 million for Oregon and nearly $190 million for Vermont. Infectious Disease: U.S. measles cases have topped 5,000, with Wisconsin reporting its first measles death in over 35 years; flu hospital admissions also jumped 38% in one week, to 8,396. Stroke Prevention: The FDA approved Bayer’s Sunharbo, the first factor XIa inhibitor in the U.S., to reduce repeat stroke risk; trial participants had 26% fewer recurrent ischemic strokes than those on placebo. Long-Term Care: U.S. News rated more than 14,600 nursing homes for 2027, designating 18% among the best. Top-rated facilities had fewer readmissions, while staffing gains across the sector remained modest.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
